Ads
related to: blockbuster sale
Search results
Surprise: Eli Lilly Is Racing Toward Yet Another Blockbuster | The Motley Fool
The Motley Fool· 23 hours agoThe pharmaceutical company has made quite a bit of noise over the past few years thanks to notable...
GSK Potential Blockbuster Asthma Drug Shows Promise in Latest Trial — Update
Morningstar· 3 days agoBy Najat Kantouar and Helena Smolak GSK's experimental drug for asthma met its goals in the latest trial, moving a treatment with potential blockbuster sales of 3 billion ...
Malayalam Movie Turbo Review: Mammootty’s Film Praised
COMINGSOON.net via Yahoo News· 21 hours agoThe latest Malayalam action comedy, Turbo, is currently in theaters. Starring Mammootty in the lead...
Stocks Lower, Nvidia Extends Climb
The Wall Street Journal· 13 hours agoAll three major indexes finished lower, with the blue-chip Dow off some 600 points. The move cut into recent gains for stocks, which have climbed for...
Stocks Give Up Gains in Afternoon, Nvidia Jumps
The Wall Street Journal· 1 day agoThe Dow and S&P 500 were on pace for weekly losses, while the Nasdaq was still in the green as Nvidia shares jumped.
Summer Cinema Crunch: Box Office Sales Off to a Slow Start in 2024
Investing.com· 1 day agoSummer Cinema Crunch: Box Office Sales Off to a Slow Start in 2024
Here's Why Merck (MRK) Stock Has Outperformed Industry YTD
Zacks via Yahoo Finance· 4 days agoMerck MRK boasts more than six blockbuster drugs in its portfolio, with PD-L1 inhibitor Keytruda...
DuPont is splitting into 3 companies ... again. What does this mean for Delaware?
Delaware Online | The News Journal via Yahoo Finance· 14 hours agoFully half of the New DuPont's business will be Safety and Protection, notably including blockbuster...
US individual annuities see record-breaking first quarter, says Limra - InvestmentNews
InvestmentNews· 2 days agoThe first three months of 2024 proved to be a blockbuster quarter for US individual annuities as...
AstraZeneca’s $80B sales plan leans on cancer drug expansion
BioPharma Dive via Yahoo Finance· 3 days agoDive Brief: AstraZeneca’s plan to reach $80 billion in sales by 2030 relies heavily on a slate of...
